Sign In
to Vote &
Create Storyboards.
 
AstraZeneca is acquiring Alexion Pharmaceuticals in a $39 billion pharmaceutical deal AstraZeneca on Saturday announced it was acquiring Alexion Pharmaceuticals in a $39 billion deal, a move intended to boost immunology research.
2
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard